Regentatlantic Capital LLC Decreases Stake in Walgreens Boots Alliance, Inc. (WBA)

Paterniano Del Favero
Agosto 25, 2017

Of those insider trades, 0 shares of Walgreens Boots Alliance, Inc. were purchased and 4,561 shares were sold. According to the ETF Finder at ETF Channel, WBA makes up 5.39% of the PowerShares Dynamic Retail Portfolio ETF (Symbol: PMR) which is trading lower by about 0.3% on the day Thursday. It helps investors in determining whether buying, selling or holding on to a stock would be beneficial for them.

A number of other large investors also recently modified their holdings of the company. Howe & Rusling Inc. raised its stake in Walgreens Boots Alliance by 209.2% in the first quarter. Nordea Investment Management AB now owns 10,085,836 shares of the pharmacy operator's stock worth $789,822,000 after buying an additional 931,508 shares in the last quarter. Wellington Management Group LLP increased its position in Walgreens Boots Alliance by 5.9% in the Q1. (NASDAQ:WBA)'s stock has performed -1.19%. WealthTrust Arizona LLC now owns 5,243 shares of the pharmacy operator's stock worth $435,000 after buying an additional 19 shares during the period.

While trading at volume below than average, Walgreens Boots Alliance, Inc. UBS Asset Management Americas Inc. now owns 4,912,489 shares of the pharmacy operator's stock worth $407,982,000 after buying an additional 914,888 shares during the period. Finally, MCF Advisors LLC raised its stake in Walgreens Boots Alliance by 68.2% in the first quarter. Nisa Investment Advisors LLC now owns 314,480 shares of the pharmacy operator's stock worth $26,118,000 after buying an additional 2,220 shares during the period.

Now investors want to know the actual market worth of the company in the Stock Market.

Dollar Tree, Inc. (DLTR) have shown a high EPS growth of 13.40% in the last 5 years and has earnings rose of 199.50% yoy.

Walgreens Boots Alliance, Inc. has a 1-year low of $75.18 and a 1-year high of $89.69.

The market capitalization of Walgreens Boots Alliance, at $88 Billion. The stock has a 50-day moving average of $79.80 and a 200-day moving average of $82.29.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, June 29th. Looking ahead to earnings forecasts, for the running fiscal period, Wall Street analysts have anticipated that the company will report 0.64 earnings per share. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. The company had revenue of $30.12 billion during the quarter, compared to analyst estimates of $29.72 billion. During the same quarter in the prior year, the firm earned $1.18 earnings per share. From the start of the calendar year, shares have been -2.73%. Its mean Altman Z-Score: 3.70 during the last 7 years, while average Beneish M-Score: -2.81 during the last 7 years. Shares repurchase programs are generally a sign that the company's board of directors believes its stock is undervalued.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 12th. Stockholders of record on Friday, August 18th will be issued a dividend of $0.40 per share. The ex-dividend date is Wednesday, August 16th. This is a boost from Walgreens Boots Alliance's previous quarterly dividend of $0.38. Walgreens Boots Alliance's dividend payout ratio (DPR) is 40.30%. "(WBA)" was originally posted by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this story on another site, it was illegally copied and republished in violation of USA & worldwide trademark and copyright legislation.

Several research analysts have issued reports on WBA shares. Zacks reduced stocks of Walgreens Boots Alliance from a "hold" recommendation to a "sell" recommendation in a analysis report on Wed, Jun 14th. Its share price has risen 0.05% in three months and is up 0.18% for the last five trades. Leerink Swann set a $86.00 price target on Walgreens Boots Alliance and gave the company a "buy" rating in a report on Friday, July 7th. At present, 6 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and fourteen have assigned a buy rating to the stock. Walgreens Boots Alliance has a consensus rating of "Buy" and an average price target of $90.81. Citigroup Inc. restated a "buy" rating on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. The company's market cap is $87.91 Billion, and the average volume is 5.28 Million. The overall volume in the last trading session was 1.77 million shares. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Recently attention has been given to shares of Walgreens Boots Alliance, Inc. The corporation is a global pharmacy-led, health and wellbeing enterprise. The Company's products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Altre relazioni OverNewsmagazine

Discuti questo articolo